2426
U. Ellervik et al. / Tetrahedron 61 (2005) 2421–2429
0.36 mmol) and Cs2CO3 (120 mg, 0.36 mmol) and the
resulting mixture was stirred at room temperature. After 2 h
the reaction mixture was diluted with CH2Cl2, washed with
water, dried (MgSO4), concentrated, co-concentrated with
toluene and chromatographed (SiO2, toluene–acetone, 10:1)
to give 5 as a white solid (93 mg, 95%). [a]2D0ZK9.1 (c 1.1,
CHCl3). 1H NMR (CDCl3): d 7.10–7.30 (m, 5H, Ar), 5.13 (t,
1H, JZ9.5 Hz, H-3), 5.01 (t, 1H, JZ9.8 Hz, H-4), 4.93 (dd,
1H, JZ9.6, 8.0 Hz, H-2), 4.45 (d, 1H, JZ8.0 Hz, H-1), 4.17
(dd, 1H, JZ12.3, 4.8 Hz, H-6), 4.05 (dd, 1H, JZ12.3,
2.4 Hz, H-6), 3.94 (ddd, 1H, JZ10.4, 7.7, 5.5 Hz, CH2),
3.57–3.65 (m, 2H, H-5, CH2), 2.97–3.07 (m, 2H, CH2), 2.00,
1.98, 1.95, 1.94 (s, 3H each, OAc). 13C NMR (CDCl3): d
170.86, 170.49, 169.60, 135.67, 129.84, 129.25, 126.65,
101.22, 72.93, 72.06, 71.35, 68.87, 68.54, 62.09, 33.45,
20.94, 20.82, 20.80. HRMS calcd for C22H28O10S (MCNa)
507.1301, found 507.1300.
1H, JZ9.6, 8.0 Hz, H-2), 4.47 (d, 1H, JZ8.0 Hz, H-1), 4.24
(dd, 1H, JZ12.3, 4.8 Hz, H-6), 4.12 (dd, 1H, JZ12.3,
2.3 Hz, H-6), 3.88–3.95 (m, 1H, CH2), 3.65–3.70 (m, 2H,
H-5, CH2), 3.10–3.25 (m, 2H, CH2), 2.09, 2.03, 2.02, 2.00
(s, 3H each, OAc), 2.00–2.05 (m, 2H, CH2). 13C NMR
(CDCl3): d 170.86, 170.43, 169.61, 169.54, 133.99, 129.57,
128.18, 100.90, 72.89, 72.08, 71.36, 68.48, 67.70, 62.03,
53.06, 23.34, 20.95, 20.87, 20.80. HRMS calcd for
C23H30O12S (MCNa) 553.1356, found 553.1346.
5.1.7. 3-Phenylsulfonyl-propyl b-D-glucopyranoside (11).
Compound 10 (23 mg, 0.040 mmol) was dissolved in
NaOMe–MeOH (1 M, 1 mL) and the resulting mixture
was stirred at room temperature. After 24 h, AcOH (5% in
MeOH) was added until neutral solution (moist pH-paper).
The mixture was concentrated and chromatographed (SiO2,
CH2Cl2–MeOH–H2O, 66:33:4) to give 11 as a clear oil
(16 mg, 99%). [a]D20ZK14.2 (c 0.5, MeOH). 1H NMR
(CD3OD): d 7.60–7.95 (m, 5H, Ar), 4.19 (d, 1H, JZ7.8 Hz,
H-1), 3.94 (dt, 1H, JZ10.1, 5.9 Hz, CH2), 3.84 (dd, 1H, JZ
12.0, 2.0 Hz, H-6), 3.60–3.67 (m, 2H, H-6, CH2), 3.20–3.45
(m, 5H, H-3, H-4, H-5, CH2), 3.14 (dd, 1H, JZ9.0, 7.9 Hz,
H-2), 1.92–2.00 (m, 2H, CH2).13C NMR (CD3OD): d
140.65, 135.17, 130.69, 129.27, 101.45, 78.11, 75.14, 71.71,
68.48, 62.87, 54.10, 24.69. HRMS calcd for C15H22O8S
(MCNa) 385.0933, found 385.0928.
5.1.4. Deprotection study of 2-(phenylsulfonyl)ethyl
2,3,4,6-tetra-O-acetyl-b-D-glucopyranoside (1). Com-
pound 1 (10 mg, 0.019 mmol) was dissolved in CD3OD
(1.0 mL) and the mixture was added to an NMR-tube and an
NMR-spectrum was recorded. CD3ONa (0.075 mL, 1 M in
CD3OD) was added and NMR-spectra were recorded after
1, 15, 30, 120, and 300 min, respectively. After 1 min, 1 was
completely deacylated and the shift of the anomeric proton
was 4.23 ppm. The amount cleaved product was determined
as the percentage of the integral for the NMR-signals of the
anomeric protons of 3 (5.18 and 4.62 ppm) compared to the
total integral for the anomeric protons of glucose and
deacetylated bromoethyl glycoside.
5.1.8. 2-(Phenylthio)ethyl b-D-glucopyranoside (12).
Compound 4 (120 mg, 0.25 mmol) was dissolved in
NaOMe–MeOH (0.05 M, 5 mL) and stirred for 45 min at
room temperature and then neutralized using Amberlite
IR-120 HC. The mixture was concentrated and chromato-
graphed (SiO2, CH2Cl2–MeOH 5:1) to give 12 as a white
solid (78 mg, 89%). [a]2D0ZK24.8 (c 0.9, MeOH). 1H NMR
(CD3OD): d 7.15–7.41 (m, 5H, Ar), 4.28 (d, 1H, JZ7.8 Hz,
H-1), 3.97 (ddd, 1H, JZ10.4, 8.2, 6.4 Hz, CH2), 3.85 (dd,
1H, JZ10.0, 2.1 Hz, H-6), 3.75 (ddd, 1H, JZ10.4, 8.2,
6.5 Hz, CH2), 3.66 (dd, 1H, JZ11.9, 5.3 Hz, H-6), 3.23–
3.37 (m, 3H, H-3, H-4, H-5), 3.15–3.21 (m, 3H, H-2, CH2).
13C NMR (CD3OD): d 137.42, 130.46, 130.21, 127.34,
104.69, 78.13, 75.18, 71.67, 69.73, 62.80, 33.91. HRMS
calcd for C14H20O6S (MCNa) 339.0878, found 339.0864.
5.1.5. 3-(Phenylthio)propyl 2,3,4,6-tetra-O-acetyl-b-D-
glucopyranoside (9). Thiophenol (0.055 mL, 0.38 mmol)
and Cs2CO3 (124 mg, 0.38 mmol) were added to a solution
of 8 (120 mg, 0.26 mmol) in DMF (5 mL) and the resulting
mixture was stirred at room temperature. After 1 h the
reaction mixture was diluted with CH2Cl2, washed with
water, dried (MgSO4), concentrated, co-concentrated with
toluene and chromatographed (SiO2, heptane–EtOAc, 3:1)
to give 9 as a pale yellow oil (135 mg, 96%). [a]2D0ZC3.4
(c 1.0, CHCl3). 1H NMR (CDCl3): d 7.08–7.26 (m, 5H, Ar),
5.13 (t, 1H, JZ9.5 Hz, H-3), 5.02 (t, 1H, JZ9.8 Hz, H-4),
4.93 (dd, 1H, JZ9.6, 8.0 Hz, H-2), 4.42 (d, 1H, JZ8.0 Hz,
H-1), 4.19 (dd, 1H, JZ12.3, 4.7 Hz, H-6), 4.06 (dd, 1H, JZ
12.3, 2.4 Hz, H-6), 3.88 (dt, 1H, JZ9.7, 5.5 Hz, CH2), 3.55–
3.65 (m, 2H, H-5, CH2), 2.85–3.95 (m, 2H, CH2), 2.01, 1.95
(s, 3H each, OAc), 1.93 (s, 6H, OAc), 1.75–1.90 (m, 2H,
CH2). 13C NMR (CDCl3): d 171.11, 170.71, 169.83, 169.75,
136.57, 129.45, 129.37, 126.38, 101.34, 73.22, 72.22, 71.70,
68.82, 68.35, 30.17, 29.26, 21.18, 21.05, 21.03. HRMS
calcd for C23H30O10S (MCNa) 521.1457, found 521.1455.
5.1.9. 2-(Phenylthio)ethyl 2,3,4,6-tetra-O-benzyl-b-D-
glucopyranoside (13). To a solution of 12 (69 mg,
0.22 mmol) in DMF (distilled, 3 mL) was added NaH
(60%, 90 mg) and BnBr (0.15 mL). The reaction mixture
was stirred for 1 h and then quenched by addition of MeOH
(1 mL). The mixture was then diluted with CH2Cl2, washed
with water, dried (Na2SO4), concentrated and chromato-
graphed (SiO2, heptane–EtOAc, 1:1) to give 13 as a white
waxy solid (131 mg, 89%). [a]2D0ZC15.9 (c 1.7, CHCl3).
1H NMR (CDCl3): d 7.10–7.35 (m, 25H, Ar), 4.95, 4.68
1
1
5.1.6. 3-(Phenylsulfonyl)propyl 2,3,4,6-tetra-O-acetyl-b-
D-glucopyranoside (10). To a solution of 9 (45 mg,
0.083 mmol) in EtOAc (2.5 mL) was added mCPBA
(53 mg, 0.18 mmol, 60%) and the resulting mixture was
stirred at room temperature. After 30 min, the mixture was
filtered through a short column of alumina, concentrated,
and chromatographed (SiO2, heptane–EtOAc, 1:2) to give
10 as a clear oil (46 mg, 97%). [a]2D0ZK12.4 (c 1.3,
CHCl3). 1H NMR (CDCl3): d 7.50–8.00 (m, 5H, Ar), 5.19 (t,
1H, JZ9.5 Hz, H-3), 5.06 (t, 1H, JZ9.8 Hz, H-4), 4.95 (dd,
(ABq, H each, JZ11.0 Hz, OBn), 4.90, 4.76 (ABq, H
1
each, JZ11.0 Hz, OBn), 4.79, 4.50 (ABq, H each, JZ
11.1 Hz, OBn), 4.57, 4.52 (ABq, 1H each, JZ12.1 Hz,
OBn), 4.35 (d, 1H, JZ7.8 Hz, H-1), 4.07 (ddd, 1H, JZ10.2,
7.7, 5.7 Hz, CH2), 3.55–3.75 (m, 5H, H-3, H-5, H-6, CH2),
3.38–3.45 (m, 2H, H-2, H-4), 3.10–3.21 (m, 2H, CH2). 13
C
NMR (CDCl3): d 138.78, 138.68, 138.30, 138.27, 135.27,
129.59, 129.19, 128.58, 128.42, 128.18, 128.08, 127.99,
127.87, 127.84, 126.40, 104.01, 84.82, 82.39, 77.94, 75.91,
75.22 75.08, 75.06, 73.70, 72.32, 69.03, 68.71, 33.49.